Ultra-structural cell distribution of the melanoma marker iodobenzamide: improved potentiality of SIMS imaging in life sciences

被引:58
作者
Guerquin-Kern, Jean-Luc [1 ]
Hillion, Francois [2 ]
Madelmont, Jean-Claude [3 ]
Labarre, Pierre [3 ]
Papon, Janine [3 ]
Croisy, Alain [1 ]
机构
[1] INSERM, Lab Raymond Latarjet, U350, Batiment 112, F-91405 Orsay, France
[2] CAMECA France, F-92403 Courbevoie, France
[3] INSERM, Ctr Rech, U484, F-63005 Clermont Ferrand, France
关键词
Melanoma; Normal Lung Tissue; Tumour Bearing Mouse; High Lateral Resolution; Iodobenzamide;
D O I
10.1186/1475-925X-3-10
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background: Analytical imaging by secondary ion mass spectrometry (SIMS) provides images representative of the distribution of a specific ion within a sample surface. For the last fifteen years, concerted collaborative research to design a new ion microprobe with high technical standards in both mass and lateral resolution as well as in sensitivity has led to the CAMECA NanoSims 50, recently introduced onto the market. This instrument has decisive capabilities, which allow biological applications of SIMS microscopy at a level previously inaccessible. Its potential is illustrated here by the demonstration of the specific affinity of a melanoma marker for melanin. This finding is of great importance for the diagnosis and/or treatment of malignant melanoma, a tumour whose worldwide incidence is continuously growing. Methods: The characteristics of the instrument are briefly described and an example of application is given. This example deals with the intracellular localization of an iodo-benzamide used as a diagnostic tool for the scintigraphic detection of melanic cells (e.g. metastasis of malignant melanoma). B16 melanoma cells were injected intravenously to C57BL6/J(1)/co mice. Multiple B16 melanoma colonies developed in the lungs of treated animals within three weeks. Iodobenzamide was injected intravenously in tumour bearing mice six hours before sacrifice. Small pieces of lung were prepared for SIMS analysis. Results: Mouse lung B16 melanoma colonies were observed with high lateral resolution. Cyanide ions gave "histological" images of the cell, representative of the distribution of C and N containing molecules (e.g. proteins, nucleic acids, melanin, etc.) while phosphorus ions are mainly produced by nucleic acids. Iodine was detected only in melanosomes, confirming the specific affinity of the drug for melanin. No drug was found in normal lung tissue. Conclusion: This study demonstrates the potential of SIMS microscopy, which allows the study of ultra structural distribution of a drug within a cell. On the basis of our observations, drug internalization via membrane sigma receptors can be excluded.
引用
收藏
页数:7
相关论文
共 19 条
[1]  
Castaing R., 1962, J MICROSC-PARIS, V1, P395
[2]   Labelled sigma receptor ligands: can their role in neurology and oncology be extended? [J].
Caveliers, V ;
Everaert, H ;
Lahoutte, T ;
Dierickx, LO ;
John, CS ;
Bossuyt, A .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (02) :133-135
[3]  
Chehade F, 2001, CELL MOL BIOL, V47, P529
[4]  
Galle P., 1970, Ann. Phys. Biol. Med, V42, P83
[5]   Epidemiology of cutaneous melanoma in Germany and worldwide [J].
Garbe, C ;
Blum, A .
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 2001, 14 (05) :280-290
[6]  
Hillion F., 1994, SECONDARY ION MASS S, P254
[7]  
JOHN CS, 1993, J NUCL MED, V34, P2169
[8]   AN IMPROVED SYNTHESIS OF [I-125] N-(DIETHYLAMINOETHYL)-4-IODOBENZAMIDE - A POTENTIAL LIGAND FOR IMAGING MALIGNANT-MELANOMA [J].
JOHN, CS ;
SAGA, T ;
KINUYA, S ;
LE, N ;
JEONG, JM ;
PAIK, CH ;
REBA, RC ;
VARMA, VM ;
MCAFEE, JG .
NUCLEAR MEDICINE AND BIOLOGY, 1993, 20 (01) :75-79
[9]   Melanin affinity of N-(2-diethylaminoethyl)-4-lodobenzamide, an effective melanoma imaging agent [J].
Labarre, P ;
Papon, J ;
Moreau, MF ;
Moins, N ;
Bayle, M ;
Veyre, A ;
Madelmont, JC .
MELANOMA RESEARCH, 2002, 12 (02) :115-121
[10]   Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting [J].
Labarre, P ;
Papon, J ;
Moreau, MF ;
Moins, N ;
Veyre, A ;
Madelmont, JC .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (05) :494-498